Wei Zhang Chu Luo Zun-Yi Zhang Bi-Xiang Zhang Xiao-Ping Chen
10.3389/fimmu.2022.1079342
Front Immunol
2023 Jan 9;13:1079342.
antiangiogenic therapy chemotherapy conversion therapy immunotherapy intrahepatic cholangiocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36700218/
Bile Duct Neoplasms / pathology Cholangiocarcinoma / pathology
Bile Duct Neoplasms / pathology Cholangiocarcinoma / pathology Review Case Reports Research Support, Non-U.S. Gov't Bile Ducts, Intrahepatic / pathology Cisplatin / therapeutic use Deoxycytidine / therapeutic use Gemcitabine Humans Male Middle Aged Gemcitabine Cisplatin lenvatinib pembrolizumab Deoxycytidine
PMC9868150
36700218
Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review
2023